AVIR — ATEA PHARMACEUTICALS INC

Ownership history in CITADEL ADVISORS LLC  ·  55 quarters on record

AI Ownership Summary

CITADEL ADVISORS LLC reported ATEA PHARMACEUTICALS INC (AVIR) in 55 quarterly 13F filings from 2023 Q3 through 2025 Q4. The latest visible filing shows AVIR at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this AVIR ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was CITADEL ADVISORS LLC's position in ATEA PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

AVIR was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q3 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

AVIR stock page CITADEL ADVISORS LLC fund profile CITADEL ADVISORS LLC full holdings
How CITADEL ADVISORS LLC held AVIR — position size vs. price
% of Fund (quarterly)    AVIR price (quarter-end, indexed to 100)
📋 Quarterly Holdings History 25 quarters  ▾
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 ADDED 42,691 +962 +2.3% 0.00% $152K 2026-02-14 (Est.) $4.31
2025 Q3 ADDED 41,729 +10,329 +32.9% 0.00% $121K 2025-11-14 $2.96
2025 Q3 ADDED 31,400 +300 +1.0% 0.00% $91K 2025-11-14 $2.96
2025 Q3 ADDED 31,100 +9,108 +41.4% 0.00% $90K 2025-11-14 $2.96
2025 Q1 ADDED 21,992 +21,592 +5398.0% 0.00% $66K 2025-05-15 $2.59
2025 Q1 REDUCED 400 -3,000 -88.2% 0.00% $1K 2025-05-15 $2.59
2025 Q1 REDUCED 3,400 -215,388 -98.4% 0.00% $10K 2025-05-15 $2.59
2024 Q4 ADDED 218,788 +214,088 +4555.1% 0.00% $733K 2025-02-14 $3.15
2024 Q4 REDUCED 4,700 -2,900 -38.2% 0.00% $16K 2025-02-14 $3.15
2024 Q4 REDUCED 7,600 -587,649 -98.7% 0.00% $25K 2025-02-14 $3.15
2024 Q3 ADDED 595,249 +566,249 +1952.6% 0.00% $2.0M 2024-11-14 $3.31
2024 Q3 ADDED 29,000 +28,100 +3122.2% 0.00% $97K 2024-11-14 $3.31
2024 Q3 REDUCED 900 -524,703 -99.8% 0.00% $3K 2024-11-14 $3.31
2024 Q2 ADDED 525,603 +386,703 +278.4% 0.00% $1.7M 2024-08-14 $3.60
2024 Q2 ADDED 138,900 +136,100 +4860.7% 0.00% $460K 2024-08-14 $3.60
2024 Q2 REDUCED 2,800 -193,200 -98.6% 0.00% $9K 2024-08-14 $3.60
2024 Q1 ADDED 196,000 +63,500 +47.9% 0.00% $792K 2024-05-15 $3.71
2024 Q1 ADDED 132,500 +119,400 +911.5% 0.00% $535K 2024-05-15 $3.71
2024 Q1 REDUCED 13,100 -159,914 -92.4% 0.00% $53K 2024-05-15 $3.71
2023 Q4 ADDED 173,014 +170,214 +6079.1% 0.00% $528K 2024-02-14 $4.02
2023 Q4 REDUCED 2,800 -11,200 -80.0% 0.00% $9K 2024-02-14 $4.02
2023 Q4 REDUCED 14,000 -570,688 -97.6% 0.00% $43K 2024-02-14 $4.02
2023 Q3 ADDED 584,688 +581,788 +20061.7% 0.00% $1.8M 2023-11-14 $3.00
2023 Q3 REDUCED 2,900 -12,700 -81.4% 0.00% $9K 2023-11-14 $3.00
2023 Q3 REDUCED 15,600 -1,466,183 -98.9% 0.00% $47K 2023-11-14 $3.00
30 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding AVIR

As of 2025 Q4 — sorted by position size

BML Capital Management, LLC 3Y 23.11% CM Management, LLC 3Y 1.07% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.85% Bain Capital Life Sciences Investors, LLC 3Y 7Y 0.68% Aldebaran Capital, LLC 3Y 0.29% Rangeley Capital, LLC 0.24% Auour Investments LLC 0.2% NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.15% Opaleye Management Inc. 3Y 7Y 0.08% Sunpointe, LLC 0.01%

FAQ About CITADEL ADVISORS LLC and AVIR

These are the practical questions this page is built to answer before you even open the full history table.

How long has CITADEL ADVISORS LLC reported owning AVIR?

CITADEL ADVISORS LLC reported AVIR across 25 quarterly 13F filings, from 2023 Q3 through 2025 Q4.

What was the largest reported AVIR position in CITADEL ADVISORS LLC's portfolio?

The largest reported portfolio weight for AVIR was 0.00% in 2024 Q3.

What is the latest reported AVIR position on this page?

The most recent filing on this page is 2025 Q4, when CITADEL ADVISORS LLC reported 42,691 shares, equal to 0.00% of portfolio, with an estimated market value of $152K.

What does the chart on this AVIR ownership page compare?

The chart compares CITADEL ADVISORS LLC's quarterly AVIR portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to CITADEL ADVISORS LLC Holdings